Section 35-48-2-8 - Schedule III(a) The controlled substances listed in this section are included in schedule III.(b) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:(1) Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in schedule II which compounds, mixtures, or preparations were listed on April 1, 1986, as excepted compounds under 21 CFR 1308.32, and any other drug of the quantitative composition shown in that list for those drugs or that is the same except that it contains a lesser quantity of controlled substances (1405).(2) Benzphetamine (1228).(3) Chlorphentermine (1645).(5) Phendimetrazine (1615).(c) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system: (1) Any compound, mixture, or preparation containing:(C) pentobarbital (2271); or(D) any of their salts; and one (1) or more other active medicinal ingredients which are not listed in any schedule.
(2) Any suppository dosage form containing: (C) pentobarbital (2271); or(D) any of their salts; and approved by the Food and Drug Administration for marketing only as a suppository.
(3) Any substance which contains any quantity of a derivative of barbituric acid, or any salt thereof (2100).(6) Lysergic acid (7300).(7) Lysergic acid amide (7310).(9) Sulfondiethylmethane (2600).(10) Sulfonethylmethane (2605).(11) Sulfonmethane (2610).(12) A combination product containing Tiletamine and Zolazepam or any salt thereof (Telazol) (7295).(13) Any drug product containing gamma-hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the federal Food, Drug and Cosmetic Act, 21 U.S.C. 301 et seq. (2012).(d) Nalorphine (a narcotic drug) (9400).(e) Narcotic Drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in the following limited quantities: (1) Not more than 1.8 grams of codeine, per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium (9803).(2) Not more than 1.8 grams of codeine, per 100 milliliters or not more than 90 milligrams per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts (9804).(3) Not more than 1.8 grams of dihydrocodeine, per 100 milliliters or not more than 90 milligrams per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts (9807).(4) Not more than 300 milligrams of ethylmorphine, per 100 milliliters or not more than 15 milligrams per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts (9808).(5) Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with one (1) or more active, nonnarcotic ingredients in recognized therapeutic amounts (9809).(6) Not more than 50 milligrams of morphine, per 100 milliliters or per 100 grams with one (1) or more active nonnarcotic ingredients in recognized therapeutic amounts (9810).(7) Buprenorphine (9064).(f) Anabolic steroid (as defined in 21 U.S.C. 802(41)(A) and 21 U.S.C. 802(41)(B)).(g) The board shall except by rule any compound, mixture, or preparation containing any stimulant or depressant substance listed in subsections (b) through (e) from the application of any part of this article if the compound, mixture, or preparation contains one (1) or more active medicinal ingredients not having a stimulant or depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion, or concentration that vitiate the potential for abuse of the substances which have a stimulant or depressant effect on the central nervous system.(h) Any material, compound, mixture, or preparation which contains any quantity of Ketamine (7285).(i) Hallucinogenic substances: Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States Food and Drug Administration approved drug product (7369).
Amended by P.L. 56-2015, SEC. 4, eff. 4/23/2015.As added by Acts1976 , P.L. 148, SEC.7. Amended by Acts1977 , P.L. 2, SEC.86; Acts1979 , P.L. 303, SEC.5; Acts1981 , P.L. 170, SEC.4; P.L. 333-1983, SEC.3; P.L. 200-1987, SEC.10; P.L. 48-1991, SEC.76; P.L. 1-1994, SEC.171; P.L. 31-1998, SEC.10; P.L. 288-2001, SEC.16; P.L. 22-2008, SEC.3.